TickerFacts.

A business in context

BSX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0001225208-26-007620

  2. 4 · Ownership change

    Report date 2026-08-25 · 0001225208-26-007337

  3. 8-K · Current report

    Report date 2026-08-26 · 0000885725-26-000056 · Items 8.01

  4. 4 · Ownership change

    Report date 2026-08-11 · 0001225208-26-007084

  5. 4 · Ownership change

    Report date 2026-08-10 · 0001225208-26-007062

  6. 4 · Ownership change

    Report date 2026-08-05 · 0001225208-26-007031

  7. 4 · Ownership change

    Report date 2026-08-03 · 0001225208-26-006951

  8. 4 · Ownership change

    Report date 2026-08-03 · 0001225208-26-006950

  9. 4 · Ownership change

    Report date 2026-07-31 · 0001225208-26-006882

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000885725-26-000053

  11. 8-K · Current report

    Report date 2026-07-29 · 0000885725-26-000051 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-07-21 · 0000885725-26-000049 · Items 2.05

  13. 8-K · Current report

    Report date 2026-05-18 · 0000885725-26-000042 · Items 8.01,9.01

  14. 8-K · Current report

    Report date 2026-05-18 · 0000885725-26-000041 · Items 8.01,9.01

  15. 8-K · Current report

    Report date 2026-04-30 · 0000885725-26-000036 · Items 5.03,5.07,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000885725-26-000033

  17. 8-K · Current report

    Report date 2026-04-22 · 0000885725-26-000031 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-03-28 · 0000885725-26-000029 · Items 8.01,9.01

  19. DEF 14A · Proxy statement

    Report date 2026-03-18 · 0000885725-26-000025

  20. 8-K · Current report

    Report date 2026-02-26 · 0000885725-26-000017 · Items 1.01,1.02,2.03,9.01

  21. 8-K · Current report

    Report date 2026-02-18 · 0000885725-26-000013 · Items 5.02,7.01,8.01,9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0000885725-26-000010

  23. 8-K · Current report

    Report date 2026-02-02 · 0000885725-26-000008 · Items 5.02

  24. 8-K · Current report

    Report date 2026-02-04 · 0000885725-26-000006 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-01-14 · 0000947871-26-000037 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2026-01-15 · 0000947871-26-000034 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-11-18 · 0000885725-25-000052 · Items 5.02,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000885725-25-000050

  29. 8-K · Current report

    Report date 2025-10-22 · 0000885725-25-000048 · Items 5.02

  30. 8-K · Current report

    Report date 2025-10-22 · 0000885725-25-000046 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-08-29 · 0000885725-25-000043 · Items 5.02

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000885725-25-000041

  33. 8-K · Current report

    Report date 2025-07-23 · 0000885725-25-000039 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-05-28 · 0000885725-25-000033 · Items 8.01

  35. 8-K · Current report

    Report date 2025-05-01 · 0000885725-25-000028 · Items 5.07

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000885725-25-000026

  37. 8-K · Current report

    Report date 2025-04-18 · 0000885725-25-000024 · Items 5.02,8.01,9.01

  38. 8-K · Current report

    Report date 2025-04-23 · 0000885725-25-000023 · Items 2.02,9.01

  39. DEF 14A · Proxy statement

    Report date 2025-03-19 · 0000885725-25-000017

  40. 8-K · Current report

    Report date 2025-02-21 · 0000885725-25-000013 · Items 1.01,2.03,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 4 transaction rows4PSale: 0 transaction rows0SGrant / award: 14 transaction rows14AExercise / conversion: 4 transaction rows4MTax / exercise payment: 2 transaction rows2FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

25 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-28
2026-06-01
Mahoney Michael FG · Gift
Disposed
Common Stock386755.00.0
2026-05-20
2026-05-21
Pegus CherylP · Purchase
Acquired
Common Stock1770.056.49
2026-05-20
2026-05-21
LUDWIG EDWARD JP · Purchase
Acquired
Common Stock3580.056.68
2026-05-20
2026-05-21
Habiger David CP · Purchase
Acquired
Common Stock2250.055.92
2026-05-19
2026-05-21
Habiger David CP · Purchase
Acquired
Common Stock2200.056.95
2026-05-07
2026-05-11
Zane Ellen MA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-07
2026-05-11
WICHMANN DAVID SA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-07
2026-05-11
Weber Christophe PierreA · Grant / award
Acquired
Common Stock1140.00.0
2026-05-07
2026-05-11
Weber Christophe PierreA · Grant / award
Acquired
Common Stock1767.00.0
2026-05-07
2026-05-11
Weber Christophe PierreA · Grant / award
Acquired
Deferred Stock Units
Derivative security
2660.00.0
2026-05-07
2026-05-11
Smith Cathy RA · Grant / award
Acquired
Deferred Stock Units
Derivative security
3800.00.0
2026-05-07
2026-05-11
Smith Cathy RA · Grant / award
Acquired
Deferred Stock Units
Derivative security
2209.00.0
2026-05-07
2026-05-11
Pegus CherylA · Grant / award
Acquired
Deferred Stock Units
Derivative security
1281.00.0
2026-05-07
2026-05-11
Pegus CherylA · Grant / award
Acquired
Deferred Stock Units
Derivative security
3800.00.0
2026-05-07
2026-05-11
Morano Susan EA · Grant / award
Acquired
Common Stock1281.00.0
2026-05-07
2026-05-11
Morano Susan EA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-07
2026-05-11
Mega Jessica LA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-07
2026-05-11
LUDWIG EDWARD JA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-07
2026-05-11
Habiger David CA · Grant / award
Acquired
Common Stock3800.00.0
2026-05-02
2026-05-04
O'Connor Padraig AndrewF · Tax / exercise payment
Disposed
Common Stock872.056.5
2026-05-02
2026-05-04
O'Connor Padraig AndrewM · Exercise / conversion
Acquired
Common Stock1802.00.0
2026-05-02
2026-05-04
O'Connor Padraig AndrewM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
1802.00.0
2026-05-02
2026-05-04
Butcher Arthur CF · Tax / exercise payment
Disposed
Common Stock1007.056.5
2026-05-02
2026-05-04
Butcher Arthur CM · Exercise / conversion
Acquired
Common Stock2102.00.0
2026-05-02
2026-05-04
Butcher Arthur CM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
2102.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000885725BOSTON SCIENTIFIC CORP
Boston Scientific ScimedBoston Scientific TechnologyBoston Scientific (Barbados)Boston Scientific Neuromodulation CorporationCardiac Pacemakers Inc.

Showing 5 of 5 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
Y6ZDD9FP4P8JSSJMW954
GLEIF legal name
BOSTON SCIENTIFIC CORPORATION
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-10-14T14:50:37Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Boston Scientific · alias · wikidata
  • Boston Scientific Corporation · alias · wikidata
  • BSC · alias · wikidata
  • Boston Scientific Scimed · subsidiary · wikidata
  • Boston Scientific Scimed, Inc. · subsidiary · wikidata
  • Boston Scientific Scimed, Inc. (Maple Grove, MN) · subsidiary · wikidata
  • Boston Scientific Technology · subsidiary · wikidata
  • Boston Scientific (Barbados) · subsidiary · wikidata
  • Boston Scientific Neuromodulation Corporation · subsidiary · wikidata
  • Boston Scientific Neuromodulation Corporation (Valencia, CA) · subsidiary · wikidata
  • Cardiac Pacemakers Inc. · subsidiary · wikidata
  • Cardiac Pacemakers, Inc. (St. Paul, MN) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$16.75B$17.83B
2023-12-31$14.24B$15.60B
2022-12-31$12.68B$14.47B
2021-12-31$11.89B$14.65B
2020-12-31$9.91B$12.79B
2019-12-31$10.73B$14.02B
2018-12-31$9.82B$13.06B
2017-12-31$9.05B$12.33B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗